Award for Research Careers in Hematology Recipients

2026

• Connie Arthur, PhD, Brigham & Women's Hospital, Immunologic Consequences of Neonatal Anemia and Its Treatment
• Nitya Bakshi, MBBS, MS, Yale School of Medicine, Plasma Proteomic Biomarkers of Sickle Cell Disease Pain
• Tessa Barrett, PhD, New York University Grossman School of Medicine, Platelet KLHDC8B as a Regulator of Thromboinflammatory Thrombosis
• Shannon Buckley, PhD, University of Utah, Deciphering Genes Associated with Trisomy 8
• Sheng Cai, MD, PhD, Memorial Sloan Kettering, Concurrent Menin Inhibition and Ikaros Degradation to Overcome Resistance in Relapsed Acute Leukemia
• Jaebok Choi, MA, PhD, The Washington University, Targeting the GAS6-TAM Axis to Prevent GvHD and Leukemia Relapse
• Marta Derecka, PhD, St. Jude Childre's Research Hospital, Elucidating Therapeutic Potential of ITGB8 Inhibition in Myelofibrosis
• Francesca Ferraro, MD, PhD, The Washington University, Mechanisms and Therapeutic Targeting of Immune Dysfunction in Acute Myeloid Leukemia
• Jacqueline Garcia, MD, Dana-Farber Cancer Insitute, Treatment Selection Using Dynamic BH3 Profiling in Patients with Relapsed or Refractory Acute Myeloid Leukemia
• Rimi Hazra, PhD, The University of Pittsburgh, Hemolysis Driven CRH-FKBP5 Axis as a Mechanistic Driver for White Matter Injury and Cognitive Impairment in Sickle Cell Disease
• R. Katherine Hyde, PhD, University of Nebraska Medical Center, Evaluation of the Nanoparticle PAMD-Ch17 as an Anti-leukemic and siRNA Delivery Agent
• Seethal Jacob, MD, MS, Trustees of Indiana University, Determinants of Access to Neurocognitive Services in Sickle Cell Disease: The Role of Caregiver Recognition
• Milka Koupenova, PhD, University of Massachusetts Chan Medical School, Mechanisms of Platelet Alarmin Release and Immunothrombosis
• Mondira Kundu, MD, PhD, St. Jude Childre's Research Hospital, Mechanisms of SEC24C-Associated Dyserythropoiesis in Fetal and Stress Erythropoiesis
• Rui Lu, PhD, University of Alabama at Birmingham, Defining a Non-catalytic Epigenetic Cofactor Dependency in Acute Myeloid Leukemia
• Patrick McGann, MD, PhD, Rhode Island Hospital, Nationwide Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Angola
• Carol Miao, PhD, Seattle Children's Research Institute, Redosable Nonviral Gene Therapy for Hemophilia A treatment
• Betty Pace, MD, Augusta University, Gamma Globin Activation via Disruption of a Cis-Regulatory Element During Erythropoiesis in Sickle Cell Disease
• Robert Paulson, PhD, The Pennsylvania State University, Role of Polyamines in Stress Erythropoiesis
• Malini Raghavan, PhD, MSc, University of Michigan, Calreticulin Mutations in Myeloproliferative Neoplasms
• Sunil Raikar, MD, Emory University, Understanding Lineage Plasticity and Improving Therapeutic Options for Pediatric B/Myeloid Mixed Phenotype Acute Leukemia
• Sarah Reeves, PhD, MPH, University of Michigan, Advancing Quality Measurement to Improve Evidence-Based Care for Sickle Cell Disease Across the Lifespan
• Marlies Rossmann, MD, PhD, University of Rochester, Role of Ferroptosis Suppression in Erythropoiesis
• Kathleen Sakamoto, MD, PhD, Board of Trustees of the Leland Stanford Junior University, Repurposing Niclosamide for Treatment of Acute Myeloid Leukemia
• Chunhua Song, DPhil, MD, The Ohio State University, Targeting Tumor Microenvironment to Reverse Immune Suppression in High-Risk T-ALL
• Athena Starlard-Davenport, PhD, University of Tennessee Health Science Center, Systems Genetics of Sickle Cell Disease: Mapping Genetic Modifiers of Disease Severity Using the SCD-BXD Mouse Resource
• Chih-Chia Su, PhD, Case Western Reserve University, Calcium-Regulated Control of Alternative Pathway Initiation: A New Paradigm in Complement Biology
• Victor Tkachev, PhD, Massachusetts General Hospital, The Gut-Leukemia Axis After Bone Marrow Transplantation
• Venee Tubman, MD, MMSc, Baylor College of Medicine, Mechanisms of B Lymphocyte Deficiency in Sickle Cell Disease
• Nan Zhu, PhD, J Craig Venter Institute, Targeting BAF Chromatin Remodeling Complex in Acute Myeloid Leukemia

ASH-Johnson & Johnson ARCH Recipients

• Heather Gustafson, PhD, Seattle Children's Research Institute, Mechanism-Based Prevention of CAR-T Neurotoxicity Through JAK2-Directed Immune Reprogramming 
• Sophia Adamia, PhD, Beth Israel Deaconess Medical Center, The CD38 RNA Therapeutics: A Strategy to Reverse Antigen Escape in Relapsed Myeloma

ASH-Regeneron ARCH Recipient

• Linda Baughn, PhD, Mayo Clinic, Aging and Immune Senescence Drive Racial Disparities in Multiple Myeloma 

2025

• Janis Abkowitz, MD, University of Washington, Contributions of aberrant heme-iron trafficking to MDS anemia
• Joseph Aslan, PhD, Oregon Health & Science University, Pathway maps of platelet phenotype and function
• Leslie Crews, PhD, The Regents of the University of California, San Diego, Core molecular regulators of lipid homeostasis in hematopoietic progenitor cell aging
• Agnieszka Czechowicz, MD, Stanford University, Understanding HSC protection in bone marrow conditioning
• David Dominguez-Sola, MD, PhD, Icahn School of Medicine at Mount Sinai, Discovery of a metabolic escape program advancing targeted therapeutics in Burkitt lymphoma
• Michael Elliott, PhD, University of South Alabama, Cytotoxic capacity of antibody-mediated phagocytosis
• Steven Josefowicz, PhD, Weill Cornell Medical Center, Central innate immune memory in BCG induced tumor immunity: mechanisms and predictors of patient response
• Peter Klein, MD, PhD, Perelman School of Medicine at University of Pennsylvania, Targeting mitophagy through PINK1 splicing in MDS
• Ying Liang, MD, PhD, New York Blood Center Enterprises, Sex dimorphism in bone marrow niche and its effect on hematopoietic transplantation
• Peisong Ma, PhD, Thomas Jefferson University, GRK5 regulation of GPCR signaling in platelets
• Punam Malik, MD, Cincinnati Children's Hospital Medical Center, Role of Fetal Hemoglobin in Hemoglobin-SC form of Sickle Cell Disease
• Steven McKenzie, MD, PhD, Thomas Jefferson University, Inflammasome in HIT
• Bethany Mundy-Bosse, PhD, The Ohio State University College of Medicine, The impact of TET2 dysfunction on immune surveillance and the development of myeloid disorder
• Marvin Nieman, PhD, Case Western Reserve University, The role of protease activated receptors on platelets
• Trista North, PhD, Boston Children's Hospital, Biomechanical activation of YAP induces hematopoietic stem cell production
• Sarah O'Brien, MD, MSc, Research Institute at Nationwide Children's Hospital, Mobile app technology for identification of abnormal uterine bleeding in early adolescents
• Hideyuki Oguro, PhD, University of Connecticut, The role of estrogen receptor signaling in clonal hematopoiesis
• Vikram Paralkar, MD, Perelman School of Medicine at University of Pennsylvania, Regulation of RNA Polymerase I by myeloid transcription factor CEBPA
• Seema Patel, PhD, Emory University, Dissecting the germinal center and extrafollicular B cell response to FVIII
• Joel Pomerantz, PhD, Johns Hopkins University School of Medicine, Mechanisms of control of lymphocyte activation and proliferation by a critical signaling integrator
• Neil Shah, MD, PhD, University of California, San Francisco, Defining mechanisms of on-target in vitro and clinical resistance to the first highly active allosteric kinase inhibitor
• Aristotelis Tsirigos, PhD, New York University Grossman School of Medicine, Identify and target epigenetic clones in acute leukemia using combined in silico and in vivo approaches
• Edmund Waller, MD, PhD, Emory University, Protective role of indoles derived from the commensal microbiota in GvHD
• Marcin Wlodarski, MD, St. Jude Children’s Research Hospital, Deciphering the mechanisms of SAMD9L mutations in bone marrow failure
• Feng-Chun Yang, MD, PhD, The University of Texas Health Science Center at San Antonio, The molecular mechanisms underlying PHF6-mutation-mediated hematologic malignancies